menu search

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Carob market worth usd 676.89 million by 2028, at a cagr of 4.55% – market research future (mrfr)

The growth drivers of the carob market include increasing consumer demand for healthy and natural alternatives, versatile applications in food and bev...

June 3, 2023, 2:37 pm

Cryptocurrency prices: here are rates of bitcoin, ethereum, dogecoin, tether

A stablecoin is an extremely low volatile cryptocurrency. Its value is tied to a physical asset like fiat currency or gold. Talking about some of the ...

June 3, 2023, 6:29 am

The weekly bottom line: hot gdp report adds to case for a rate hike

U.S. Highlights Congress passes a deal to suspend the debt limit, averting the “worst case scenario” of a default. Today’s Nonfarm Payrolls Repo...

June 3, 2023, 3:45 am

The cash alternatives etf with a distribution yield above 6%

Cash alternatives continue to be particularly appealing this year given market stress and investor uncertainty. The NEOS Enhanced Income Cash Alternat...

June 2, 2023, 7:54 pm

Buy these 3 top-ranked etfs and never sell

Investors seeking long-term growth and diversification often turn to Exchange-Traded Funds (ETFs) as a reliable investment option. With their unique a...

June 2, 2023, 5:55 pm

Bbbyq stock: buy buy baby draws takeover interest amid bed bath & beyond bankruptcy

In a lesson to bears that targeting beleaguered enterprises isn't always the best idea, Bed Bath & Beyond (OTCMKTS: BBBYQ ) stock is ...

June 2, 2023, 2:29 pm

Why stratasys, 3d systems, and desktop metal stocks all popped today

Nano Dimension wants to buy most of Stratasys. Meanwhile, Stratasys wants to buy all of Desktop Metal....

June 2, 2023, 1:31 pm

Selectivity matters for esg investors looking to avoid greenwashing

Despite political backlash and intensifying regulatory scrutiny, environmental, social, and governance (ESG) strategies remain ...

June 2, 2023, 11:41 am

Biontech surges on this promising update in its bid to take on bristol myers in lung cancer treatment

BioNTech said Friday almost a third of patients with a hard-to-treat form of lung cancer responded to its treatment — and BNTX stock ...

June 2, 2023, 11:11 am

Chemical stock pops on billion-dollar settlement

Dupont De Nemours Inc (NYSE:DD) stock is gapping higher today after news that the chemical name is joining Corteva (CTVA) and Chemours (CC) in settin...

June 2, 2023, 10:49 am

Airbnb faces early checkout in florence and new york

Holiday goers planning a trip to the historic centre of Florence, Italy, may need to look for accommodation a bit further out. This is because the Ita...

June 2, 2023, 9:57 am

Hacked twitter account of openai cto promotes crypto scam

The Twitter account of Mira Murati, the Chief Technology Officer of OpenAI, was recently hacked, promoting a “scam” cryptocurrency airdrop. The �...

June 2, 2023, 7:54 am


Search within

Pages Search Results: